Why Is Hims & Hers Health Stock Trading Higher Today? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers buys Australian digital health firm for $1.15bn

Hims & Hers, facing a threat to its compounded medicines business, has ramped up its push for international expansion by buying Eucalyptus Health

Hims to buy Eucalyptus as it looks to expand globally

The deal, which includes $240 million upfront, was framed as one that could help Hims & Hers become a leading telehealth player globally.

Hims & Hers Health to acquire Australia's Eucalyptus for up to $1.15 billion

The deal would ⁠give Hims & Hers a foothold in Australia and Japan while deepening its presence in ‌the United Kingdom, Germany, and Canada.

Eucalyptus sells to New York-listed healthcare giant in $1.6b deal

The transaction came after the Australian start-up was raising capital, and means a major payday for 35-year-old co-founder Tim Doyle and its venture backers.

Why Is Hims & Hers Health Stock Trading Higher Today? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers stock rises premarket after announcing a $1.15 billion deal to acquire Eucalyptus and expand global reach.

Telehealth giant Eucalyptus sold to US firm - Medical Republic

California-based telehealth company Hims & Hers will pay more than $1.6 billion for Eucalyptus’ Australian, UK, Japanese and Canadian online clinics.